Results 201 to 210 of about 19,480 (219)

Management of hepatorenal syndrome in patients with cirrhosis

Nature Reviews Nephrology, 2011
Vicente Arroyo, Javier Fernández
exaly  

Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study

Journal of Hepatology, 2007
A Ottobrelli, Silvia Martini, F Balzola   +2 more
exaly  

Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome

Lancet, The, 1997
K A Brensing, J Textor, Tilman Sauerbruch   +2 more
exaly  

Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis

Digestive and Liver Disease, 2018
Martin Rosle, Fuliang He, Fuquan Liu
exaly  

Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study

Gastroenterology, 2008
Marta Martín-Llahí, German Soriano, Emilio Fabrega   +2 more
exaly  

Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome

Clinical Gastroenterology and Hepatology, 2017
Florence Wong, Stephen Chris Pappas, Thomas D Boyer   +2 more
exaly  

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

Journal of Hepatology, 2000
Juan Uriz, Père Gines, Pau Sort
exaly  

Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: A case–control study

Digestive and Liver Disease, 2009
A Marzano
exaly  

Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study

Journal of Hepatology, 2004
Père Gines, Miquel Navasa, Antoni Rimola   +2 more
exaly  

Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis

Digestive and Liver Disease, 2017
Wai-Kay Seto, James Fung, Kenneth S H Chok   +2 more
exaly